{"url_path":"/sec/scyx/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-11","source_url":"https://www.sec.gov/Archives/edgar/data/1178253/0001178253-26-000011-index.html","accession_number":"0001178253-26-000011","cik":"0001178253","ticker":"SCYX","issuer_name":"SCYNEXIS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1178253/0001178253-26-000011-index.html","primary_entity_key":"0001178253","primary_entity_name":"SCYNEXIS INC"},"word_count":82,"has_tables":true,"body_markdown":"Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.\n\nThe information required by this Item was previously reported on our Current Report on Form 8-K filed with the SEC on March 30, 2026, which is incorporated herein by reference. The shares of common stock, Pre-Funded Warrants and Common Warrants issued in connection with the March 2026 Private Placement were issued without registration under the Securities Act in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act."}